* Biomerica Inc BMRA.OQ BMRA.O is expected to show a
fall in
quarterly revenue when it reports results on April 12
(estimated).
* The Irvine California-based company is expected to report
a
20.2% decrease in revenue to $2.897 million from $3.63 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data.
* Refinitiv's mean analyst estimate for Biomerica Inc is
for a
loss of 10 cents per share. For the same quarter last year, the
company reported a loss of 15 cents per share.
* The one available analyst rating on the shares is "strong
buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Biomerica
Inc is
$13, above its last closing price of $4.43.
This summary was machine generated April 8 at 20:06 GMT. All
figures in US dollars unless otherwise stated